Kristine Deleon-pennell to Biomarkers
This is a "connection" page, showing publications Kristine Deleon-pennell has written about Biomarkers.
Connection Strength
0.412
-
Cell free DNA as a diagnostic and prognostic marker for cardiovascular diseases. Clin Chim Acta. 2020 Apr; 503:145-150.
Score: 0.113
-
An Offer We Cannot Refuse: Cell-Free DNA as a Novel Biomarker of Myocardial Infarction. Am J Med Sci. 2018 08; 356(2):88-89.
Score: 0.101
-
Matrix Metalloproteinases in Myocardial Infarction and Heart Failure. Prog Mol Biol Transl Sci. 2017; 147:75-100.
Score: 0.093
-
Exogenous IL-4 shuts off pro-inflammation in neutrophils while stimulating anti-inflammation in macrophages to induce neutrophil phagocytosis following myocardial infarction. J Mol Cell Cardiol. 2020 08; 145:112-121.
Score: 0.029
-
Transition of Macrophages to Fibroblast-Like Cells in Healing?Myocardial Infarction. J Am Coll Cardiol. 2019 12 24; 74(25):3124-3135.
Score: 0.028
-
Understanding cardiac extracellular matrix remodeling to develop biomarkers of myocardial infarction outcomes. Matrix Biol. 2019 01; 75-76:43-57.
Score: 0.025
-
Early matrix metalloproteinase-9 inhibition post-myocardial infarction worsens cardiac dysfunction by delaying inflammation resolution. J Mol Cell Cardiol. 2016 Nov; 100:109-117.
Score: 0.023